Literature DB >> 23512137

[Epstein-Barr virus-associated lymphoproliferations and lymphomas].

I Anagnostopoulos1, K Jöhrens.   

Abstract

Epstein-Barr virus (EBV) is a lymphotropic herpesvirus infecting > 95 % of the worldwide population. In case of an immunodeficiency of various causes, the virus may lead to the development of a wide spectrum of lymphoproliferations and lymphomas. This encompasses mononucleosis-like lymphoproliferations, hyperplasias of various B-cell subsets as well as aggressive non-Hodgkin lymphomas and classical Hodgkin lymphoma. These lesions occur frequently extranodal and present with a polymorphous histology with angioinvasion and necrosis. Clinical data combined with the immunohistological detection of CD30 expression in the activated infected cells and the demonstration of EBV-encoded proteins and RNA transcripts are helpful for achieving precise classification of these lesions.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23512137     DOI: 10.1007/s00292-013-1750-9

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  22 in total

1.  The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators.

Authors:  R Feederle; M Kost; M Baumann; A Janz; E Drouet; W Hammerschmidt; H J Delecluse
Journal:  EMBO J       Date:  2000-06-15       Impact factor: 11.598

Review 2.  Persistence of the Epstein-Barr virus and the origins of associated lymphomas.

Authors:  David A Thorley-Lawson; Andrew Gross
Journal:  N Engl J Med       Date:  2004-03-25       Impact factor: 91.245

3.  Clinicopathological features of pyothorax-associated lymphoma; a retrospective survey involving 98 patients.

Authors:  H Narimatsu; Y Ota; M Kami; K Takeuchi; R Suzuki; K Matsuo; T Matsumura; K Yuji; Y Kishi; T Hamaki; U Sawada; S Miyata; T Sasaki; K Tobinai; M Kawabata; Y Atsuta; Y Tanaka; R Ueda; S Nakamura
Journal:  Ann Oncol       Date:  2006-10-16       Impact factor: 32.976

4.  Geographic variation in the prevalence of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly: a comparative analysis of a Mexican and a German population.

Authors:  Annegret Hofscheier; Ana Ponciano; Irina Bonzheim; Patrick Adam; Carmen Lome-Maldonado; Teresa Vela; Evelyn Cortes; Carlos Ortiz-Hidalgo; Falko Fend; Leticia Quintanilla-Martinez
Journal:  Mod Pathol       Date:  2011-04-15       Impact factor: 7.842

5.  Infectious mononucleosis mimicking lymphoma: distinguishing morphological and immunophenotypic features.

Authors:  Abner Louissaint; Judith A Ferry; Chad P Soupir; Robert P Hasserjian; Nancy L Harris; Lawrence R Zukerberg
Journal:  Mod Pathol       Date:  2012-05-25       Impact factor: 7.842

6.  Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial.

Authors:  Ralf Trappe; Stephan Oertel; Veronique Leblond; Peter Mollee; Monica Sender; Petra Reinke; Ruth Neuhaus; Hans Lehmkuhl; Heinz August Horst; Gilles Salles; Franck Morschhauser; Arnaud Jaccard; Thierry Lamy; Malte Leithäuser; Heiner Zimmermann; Ioannis Anagnostopoulos; Martine Raphael; Hanno Riess; Sylvain Choquet
Journal:  Lancet Oncol       Date:  2011-12-13       Impact factor: 41.316

Review 7.  bZIP proteins of human gammaherpesviruses.

Authors:  Alison J Sinclair
Journal:  J Gen Virol       Date:  2003-08       Impact factor: 3.891

Review 8.  Spectrum of Epstein-Barr virus-associated diseases.

Authors:  J L Kutok; F Wang
Journal:  Annu Rev Pathol       Date:  2006       Impact factor: 23.472

9.  Epstein-Barr virus-positive diffuse large B-cell lymphoma in elderly patients is rare in Western populations.

Authors:  Sylvia Hoeller; Alexandar Tzankov; Stefano A Pileri; Philip Went; Stephan Dirnhofer
Journal:  Hum Pathol       Date:  2009-11-13       Impact factor: 3.466

10.  Senile EBV+ B-cell lymphoproliferative disorders: a clinicopathologic study of 22 patients.

Authors:  Takashi Oyama; Koichi Ichimura; Ritsuro Suzuki; Junji Suzumiya; Koichi Ohshima; Yasushi Yatabe; Takio Yokoi; Masaru Kojima; Yoshikazu Kamiya; Hirofumi Taji; Yoshitoyo Kagami; Michinori Ogura; Hidehiko Saito; Yasuo Morishima; Shigeo Nakamura
Journal:  Am J Surg Pathol       Date:  2003-01       Impact factor: 6.394

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.